Lataa...
Targeting interleukin-22 for cancer therapy
Interleukin-22 (IL-22) is a member of IL-10 family of cytokines. IL-22 induces proliferative and anti-apoptotic signaling pathways and production of anti-microbial molecules that enhance tissue regeneration and host defense. IL-22 has also been identified as a cancer-promoting cytokine since deregul...
Tallennettuna:
| Julkaisussa: | Hum Vaccin Immunother |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6149728/ https://ncbi.nlm.nih.gov/pubmed/29617184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1461300 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|